We demonstrate that the tetravalent S1 subunit protein COVID-19 vaccine candidate induces CD4+ and CD8+ T cell activation, as indicated by increased expression of CD69, HLA-DR, CD38, and Ki-67 activation and proliferation markers on both T cell subsets (Fig. 6). This evidence concerns the gene CD38 and COVID-19.